These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 11170631)
1. Synthesis and characterization of fluorescent and photoactivatable MIP-1alpha ligands and interactions with chemokine receptors CCR1 and CCR5. Zoffmann S; Turcatti G; Galzi J; Dahl M; Chollet A J Med Chem; 2001 Jan; 44(2):215-22. PubMed ID: 11170631 [TBL] [Abstract][Full Text] [Related]
2. Identification of the extracellular loop 2 as the point of interaction between the N terminus of the chemokine MIP-1alpha and its CCR1 receptor. Zoffmann S; Chollet A; Galzi JL Mol Pharmacol; 2002 Sep; 62(3):729-36. PubMed ID: 12181451 [TBL] [Abstract][Full Text] [Related]
3. Aminooxypentane addition to the chemokine macrophage inflammatory protein-1alpha P increases receptor affinities and HIV inhibition. Townson JR; Graham GJ; Landau NR; Rasala B; Nibbs RJ J Biol Chem; 2000 Dec; 275(50):39254-61. PubMed ID: 11005816 [TBL] [Abstract][Full Text] [Related]
4. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells. Oba Y; Lee JW; Ehrlich LA; Chung HY; Jelinek DF; Callander NS; Horuk R; Choi SJ; Roodman GD Exp Hematol; 2005 Mar; 33(3):272-8. PubMed ID: 15730850 [TBL] [Abstract][Full Text] [Related]
5. A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors. Blanpain C; Buser R; Power CA; Edgerton M; Buchanan C; Mack M; Simmons G; Clapham PR; Parmentier M; Proudfoot AE J Leukoc Biol; 2001 Jun; 69(6):977-85. PubMed ID: 11404385 [TBL] [Abstract][Full Text] [Related]
6. Examination of the function of RANTES, MIP-1alpha, and MIP-1beta following interaction with heparin-like glycosaminoglycans. Ali S; Palmer AC; Banerjee B; Fritchley SJ; Kirby JA J Biol Chem; 2000 Apr; 275(16):11721-7. PubMed ID: 10766793 [TBL] [Abstract][Full Text] [Related]
7. Characterization of binding sites for chemokines MCP-1 and MIP-1alpha on human brain microvessels. Andjelkovic AV; Pachter JS J Neurochem; 2000 Nov; 75(5):1898-906. PubMed ID: 11032879 [TBL] [Abstract][Full Text] [Related]
8. The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle. Blanpain C; Doranz BJ; Bondue A; Govaerts C; De Leener A; Vassart G; Doms RW; Proudfoot A; Parmentier M J Biol Chem; 2003 Feb; 278(7):5179-87. PubMed ID: 12466283 [TBL] [Abstract][Full Text] [Related]
9. Distinct expression of CCR1 and CCR5 in glomerular and interstitial lesions of human glomerular diseases. Furuichi K; Wada T; Sakai N; Iwata Y; Yoshimoto K; Shimizu M; Kobayashi K; Takasawa K; Kida H; Takeda SI; Mukaida N; Matsushima K; Yokoyama H Am J Nephrol; 2000; 20(4):291-9. PubMed ID: 10970982 [TBL] [Abstract][Full Text] [Related]
10. Role of C-C chemokine receptors 1 and 5 and CCL3/macrophage inflammatory protein-1alpha in the cutaneous Arthus reaction: possible attenuation of their inhibitory effects by compensatory chemokine production. Yanaba K; Mukaida N; Matsushima K; Murphy PM; Takehara K; Sato S Eur J Immunol; 2004 Dec; 34(12):3553-61. PubMed ID: 15517609 [TBL] [Abstract][Full Text] [Related]
11. Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils. Struyf S; Menten P; Lenaerts JP; Put W; D'Haese A; De Clercq E; Schols D; Proost P; Van Damme J Eur J Immunol; 2001 Jul; 31(7):2170-8. PubMed ID: 11449371 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the signal transduction pathway activated in human monocytes and dendritic cells by MPIF-1, a specific ligand for CC chemokine receptor 1. Nardelli B; Tiffany HL; Bong GW; Yourey PA; Morahan DK; Li Y; Murphy PM; Alderson RF J Immunol; 1999 Jan; 162(1):435-44. PubMed ID: 9886417 [TBL] [Abstract][Full Text] [Related]
14. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4. Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559 [TBL] [Abstract][Full Text] [Related]
15. LD78beta, a non-allelic variant of human MIP-1alpha (LD78alpha), has enhanced receptor interactions and potent HIV suppressive activity. Nibbs RJ; Yang J; Landau NR; Mao JH; Graham GJ J Biol Chem; 1999 Jun; 274(25):17478-83. PubMed ID: 10364178 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of the chemokine receptor, hCCR1 in a stable transfectant and differentiated HL-60 cells: antagonism of hCCR1 activation by MIP-1beta. Chou CC; Fine JS; Pugliese-Sivo C; Gonsiorek W; Davies L; Deno G; Petro M; Schwarz M; Zavodny PJ; Hipkin RW Br J Pharmacol; 2002 Nov; 137(5):663-75. PubMed ID: 12381680 [TBL] [Abstract][Full Text] [Related]
17. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium. Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880 [TBL] [Abstract][Full Text] [Related]
19. The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1alpha and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation. Pease JE; Wang J; Ponath PD; Murphy PM J Biol Chem; 1998 Aug; 273(32):19972-6. PubMed ID: 9685332 [TBL] [Abstract][Full Text] [Related]